logo

For the Inventor, By the Inventor

Frankfurt, Germany

Karl Geisen

This inventor holds 34 USPTO granted patents, plus 2 CIPO patents, primarily in Pharmaceutical Compounds. Top assignees: Hoechst Aktiengesellschaft, Aventis Pharma Deutschland, Gmbh. Active years: 1978-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl Geisen. Retrieved from https://idiyas.com/inventor/karl-geisen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.7

ph-index = 13

Forward Citations = 474(Granted Patents)


Company Filing History:

goldMedal19 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents
silverMedal15 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents

Years Active: 1978-2004

Loading Chart...
Loading Chart...
Areas of Expertise:
Insulin Derivatives
Polycyclic Thiazoles
Antidiabetic Agents
Zinc Binding
Obesity Treatment
Pharmaceutical Preparations
Pyrimidine Derivatives
Sulfonyl Ureas
Dihydrothiazoles
Quinoxalyl-Guanidines
Benzoic Acid Derivatives
Medicinal Chemistry
34 patents (USPTO):Explore Patents
1. 6686177 - Insulin analogs with enhanced zinc binding (2004-02-03),
2. 6476059 - Use of polycyclic 2-aminothiazole systems for the treatment of obesity (2002-11-05),
3. 6329407 - Use of polycyclic thiazole systems for the treatment of obesity (2001-12-11),
4. 6291486 - Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals (2001-09-18),
5. 6288094 - Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments (2001-09-11),
6. 6288093 - Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments (2001-09-11),
7. 6251922 - Polycyclic 2- aminothiazole systems, processes for their preparation and pharmaceuticals comprising these compounds (2001-06-26),
8. 6235763 - Polycyclic 2-aminodihydrothiazole systems, processes for their preparation and their use as pharmaceuticals (2001-05-22),
9. 6221837 - Insulin derivatives with increased zinc binding (2001-04-24),
10. 6221633 - Insulin derivatives having a rapid onset of action (2001-04-24),
11. 6207689 - Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments (2001-03-27),
12. 6187801 - Polycyclic thiazole systems, processes for their preparation and pharmaceuticals comprising these compounds (2001-02-13),
13. 6159996 - Polycyclic thiazolidin-2-ylidene amines, process for their preparation, (2000-12-12),
14. 6156755 - Use of pyrimidine derivatives for the prevention of cancer, on their own (2000-12-05),
15. 6090833 - Polycyclic dihydrothiazoles, their preparation, and use as (2000-07-18),

Title: The Innovative Mind of Karl Geisen: A Journey Through His Patents and Career

Introduction

Karl Geisen, a notable inventor based in Frankfurt-am-Main, Germany, has made remarkable contributions to the field of pharmaceuticals. With a significant portfolio of 34 patents, his work primarily focuses on addressing complex health issues, such as diabetes and obesity.

Latest Patents

Among his latest groundbreaking patents are:

1. **Insulin Analogues with Enhanced Zinc Binding**: This invention relates to insulin analogs that exhibit enhanced zinc binding capacity. It describes stable zinc complexes that present retarded activity when compared to human insulin. The patent outlines a method for producing these analogs and emphasizes their application in pharmaceutical preparations for the therapy of type I and type II diabetes mellitus.

2. **Use of Polycyclic 2-Aminothiazole Systems for the Treatment of Obesity**: This patent introduces innovative compounds aimed at treating obesity, further expanding the scope of Karl Geisen's contributions to healthcare.

Career Highlights

Karl Geisen has garnered extensive experience working with renowned companies such as Hoechst Aktiengesellschaft and Aventis Pharma Deutschland GmbH. His tenure at these organizations allowed him to hone his skills and innovate in the pharmaceutical industry.

Collaborations

Throughout his career, Geisen has collaborated with esteemed colleagues, including Hans-Jochen Lang and Rudi Weyer. These partnerships have facilitated the development of significant inventions, showcasing the importance of teamwork in the realm of innovation.

Conclusion

In conclusion, Karl Geisen's prolific achievements as an inventor underscore his dedication to developing solutions for critical health challenges. His patents not only reflect his innovative spirit but also highlight the collaborative efforts within the pharmaceutical industry, marking him as a pivotal figure in modern medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…